 | • レポートコード：D0804-14880 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、125ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、バクテリオファージ治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。バクテリオファージ治療の種類別市場規模（経口、局所、非経口）、用途別市場規模（臓器移植、細菌感染症、アルコール性肝炎、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Armata Pharmaceuticals, Inc.、Locus Biosciences, Inc.、Intralytix, Inc.、Eliava Biopreparations Ltd.、InnoPhage, Ltd、Pherecydes Pharma、Eligo Bioscience SA、Nextbiotics、Phagelux Inc.、TechnoPhage、Intodeworld, Inc.、Fixed-phage Ltd.、Phagomed Biopharma GmbH.、ContraFect Corporation、BiomX Ltd.、EnBiotix, Inc.、PhagePro, Inc.、Micreos BV、Phi Therapeutics、Adaptive Phage Therapeutics, Inc. ・地域別グローバル市場分析 2015年-2020年 ・バクテリオファージ治療の北米市場（アメリカ、カナダ、メキシコ） ・バクテリオファージ治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・バクテリオファージ治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・バクテリオファージ治療の南米市場（ブラジル、アルゼンチン） ・バクテリオファージ治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口、局所、非経口 ・用途別分析：臓器移植、細菌感染症、アルコール性肝炎、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Bacteriophage Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Bacteriophage Therapy sales will be xx in 2020 from Bacteriophage Therapy million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Bacteriophage Therapy market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Bacteriophage Therapy industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Bacteriophage Therapy and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Bacteriophage Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Bacteriophage Therapy market has been segmented into:
Oral
Topical
Parenteral
By Application, Bacteriophage Therapy has been segmented into:
Organ Transplantation
Bacterial Infections
Alcoholic Hepatitis
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Bacteriophage Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Bacteriophage Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Bacteriophage Therapy market.
The report offers in-depth assessment of the growth and other aspects of the Bacteriophage Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Bacteriophage Therapy Market Share Analysis
Bacteriophage Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Bacteriophage Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Bacteriophage Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Bacteriophage Therapy are:
Armata Pharmaceuticals, Inc.
Locus Biosciences, Inc.
Intralytix, Inc.
Eliava Biopreparations Ltd.
InnoPhage, Ltd
Pherecydes Pharma
Eligo Bioscience SA
Nextbiotics
Phagelux Inc.
TechnoPhage
Intodeworld, Inc.
Fixed-phage Ltd.
Phagomed Biopharma GmbH.
ContraFect Corporation
BiomX Ltd.
EnBiotix, Inc.
PhagePro, Inc.
Micreos BV
Phi Therapeutics
Adaptive Phage Therapeutics, Inc.
Among other players domestic and global, Bacteriophage Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Bacteriophage Therapy Market Overview
1.1 Product Overview and Scope of Bacteriophage Therapy
1.2 Classification of Bacteriophage Therapy by Route of Administration
1.2.1 Global Bacteriophage Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Bacteriophage Therapy Revenue Market Share by Route of Administration in 2019
1.2.3 Oral
1.2.4 Topical
1.2.5 Parenteral
1.3 Global Bacteriophage Therapy Market by Application
1.3.1 Overview: Global Bacteriophage Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Organ Transplantation
1.3.3 Bacterial Infections
1.3.4 Alcoholic Hepatitis
1.3.5 Other
1.4 Global Bacteriophage Therapy Market by Regions
1.4.1 Global Bacteriophage Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Bacteriophage Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Bacteriophage Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Bacteriophage Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bacteriophage Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Bacteriophage Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bacteriophage Therapy Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Bacteriophage Therapy Industry Impact
1.5.1 COVID-19 Potential Implications for the Bacteriophage Therapy
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Bacteriophage Therapy
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Armata Pharmaceuticals, Inc.
2.1.1 Armata Pharmaceuticals, Inc. Details
2.1.2 Armata Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Armata Pharmaceuticals, Inc. SWOT Analysis
2.1.4 Armata Pharmaceuticals, Inc. Product and Services
2.1.5 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Locus Biosciences, Inc.
2.2.1 Locus Biosciences, Inc. Details
2.2.2 Locus Biosciences, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Locus Biosciences, Inc. SWOT Analysis
2.2.4 Locus Biosciences, Inc. Product and Services
2.2.5 Locus Biosciences, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Intralytix, Inc.
2.3.1 Intralytix, Inc. Details
2.3.2 Intralytix, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Intralytix, Inc. SWOT Analysis
2.3.4 Intralytix, Inc. Product and Services
2.3.5 Intralytix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eliava Biopreparations Ltd.
2.4.1 Eliava Biopreparations Ltd. Details
2.4.2 Eliava Biopreparations Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eliava Biopreparations Ltd. SWOT Analysis
2.4.4 Eliava Biopreparations Ltd. Product and Services
2.4.5 Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 InnoPhage, Ltd
2.5.1 InnoPhage, Ltd Details
2.5.2 InnoPhage, Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 InnoPhage, Ltd SWOT Analysis
2.5.4 InnoPhage, Ltd Product and Services
2.5.5 InnoPhage, Ltd Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pherecydes Pharma
2.6.1 Pherecydes Pharma Details
2.6.2 Pherecydes Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pherecydes Pharma Product and Services
2.6.4 Pherecydes Pharma Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 Eligo Bioscience SA
2.7.1 Eligo Bioscience SA Details
2.7.2 Eligo Bioscience SA Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Eligo Bioscience SA Product and Services
2.7.4 Eligo Bioscience SA Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 Nextbiotics
2.8.1 Nextbiotics Details
2.8.2 Nextbiotics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Nextbiotics Product and Services
2.8.4 Nextbiotics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Phagelux Inc.
2.9.1 Phagelux Inc. Details
2.9.2 Phagelux Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Phagelux Inc. Product and Services
2.9.4 Phagelux Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.10 TechnoPhage
2.10.1 TechnoPhage Details
2.10.2 TechnoPhage Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 TechnoPhage Product and Services
2.10.4 TechnoPhage Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.11 Intodeworld, Inc.
2.11.1 Intodeworld, Inc. Details
2.11.2 Intodeworld, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Intodeworld, Inc. Product and Services
2.11.4 Intodeworld, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.12 Fixed-phage Ltd.
2.12.1 Fixed-phage Ltd. Details
2.12.2 Fixed-phage Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Fixed-phage Ltd. Product and Services
2.12.4 Fixed-phage Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.13 Phagomed Biopharma GmbH.
2.13.1 Phagomed Biopharma GmbH. Details
2.13.2 Phagomed Biopharma GmbH. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Phagomed Biopharma GmbH. Product and Services
2.13.4 Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.14 ContraFect Corporation
2.14.1 ContraFect Corporation Details
2.14.2 ContraFect Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 ContraFect Corporation Product and Services
2.14.4 ContraFect Corporation Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.15 BiomX Ltd.
2.15.1 BiomX Ltd. Details
2.15.2 BiomX Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 BiomX Ltd. Product and Services
2.15.4 BiomX Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.16 EnBiotix, Inc.
2.16.1 EnBiotix, Inc. Details
2.16.2 EnBiotix, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 EnBiotix, Inc. Product and Services
2.16.4 EnBiotix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.17 PhagePro, Inc.
2.17.1 PhagePro, Inc. Details
2.17.2 PhagePro, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 PhagePro, Inc. Product and Services
2.17.4 PhagePro, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.18 Micreos BV
2.18.1 Micreos BV Details
2.18.2 Micreos BV Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Micreos BV Product and Services
2.18.3 Micreos BV Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.19 Phi Therapeutics
2.19.1 Phi Therapeutics Details
2.19.2 Phi Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Phi Therapeutics Product and Services
2.19.4 Phi Therapeutics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.20 Adaptive Phage Therapeutics, Inc.
2.20.1 Adaptive Phage Therapeutics, Inc. Details
2.20.2 Adaptive Phage Therapeutics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Adaptive Phage Therapeutics, Inc. Product and Services
2.20.4 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Bacteriophage Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Bacteriophage Therapy Players Market Share
3.2.2 Top 10 Bacteriophage Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Bacteriophage Therapy Revenue and Market Share by Regions
4.2 North America Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
4.5 South America Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
5 North America Bacteriophage Therapy Revenue by Countries
5.1 North America Bacteriophage Therapy Revenue by Countries (2015-2020)
5.2 USA Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
6 Europe Bacteriophage Therapy Revenue by Countries
6.1 Europe Bacteriophage Therapy Revenue by Countries (2015-2020)
6.2 Germany Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
6.3 UK Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
6.4 France Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Bacteriophage Therapy Revenue by Countries
7.1 Asia-Pacific Bacteriophage Therapy Revenue by Countries (2015-2020)
7.2 China Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
7.5 India Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
8 South America Bacteriophage Therapy Revenue by Countries
8.1 South America Bacteriophage Therapy Revenue by Countries (2015-2020)
8.2 Brazil Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Bacteriophage Therapy by Countries
9.1 Middle East & Africa Bacteriophage Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Bacteriophage Therapy Revenue and Market Share by Route of Administration (2015-2020)
10.2 Global Bacteriophage Therapy Market Forecast by Route of Administration (2019-2024)
10.3 Oral Revenue Growth Rate (2015-2025)
10.4 Topical Revenue Growth Rate (2015-2025)
10.5 Parenteral Revenue Growth Rate (2015-2025)
11 Global Bacteriophage Therapy Market Segment by Application
11.1 Global Bacteriophage Therapy Revenue Market Share by Application (2015-2020)
11.2 Bacteriophage Therapy Market Forecast by Application (2019-2024)
11.3 Organ Transplantation Revenue Growth (2015-2020)
11.4 Bacterial Infections Revenue Growth (2015-2020)
11.5 Alcoholic Hepatitis Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Bacteriophage Therapy Market Size Forecast (2021-2025)
12.1 Global Bacteriophage Therapy Market Size Forecast (2021-2025)
12.2 Global Bacteriophage Therapy Market Forecast by Regions (2021-2025)
12.3 North America Bacteriophage Therapy Revenue Market Forecast (2021-2025)
12.4 Europe Bacteriophage Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Bacteriophage Therapy Revenue Market Forecast (2021-2025)
12.6 South America Bacteriophage Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Bacteriophage Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Bacteriophage Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Bacteriophage Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Bacteriophage Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Bacteriophage Therapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Bacteriophage Therapy Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Armata Pharmaceuticals, Inc. Corporate Information, Location and Competitors
Table 7. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Major Business
Table 8. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 9. Armata Pharmaceuticals, Inc. SWOT Analysis
Table 10. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product and Solutions
Table 11. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Locus Biosciences, Inc. Corporate Information, Location and Competitors
Table 13. Locus Biosciences, Inc. Bacteriophage Therapy Major Business
Table 14. Locus Biosciences, Inc. Bacteriophage Therapy Total Revenue (USD Million) (2018-2019)
Table 15. Locus Biosciences, Inc. SWOT Analysis
Table 16. Locus Biosciences, Inc. Bacteriophage Therapy Product and Solutions
Table 17. Locus Biosciences, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Intralytix, Inc. Corporate Information, Location and Competitors
Table 19. Intralytix, Inc. Bacteriophage Therapy Major Business
Table 20. Intralytix, Inc. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 21. Intralytix, Inc. SWOT Analysis
Table 22. Intralytix, Inc. Bacteriophage Therapy Product and Solutions
Table 23. Intralytix, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Eliava Biopreparations Ltd. Corporate Information, Location and Competitors
Table 25. Eliava Biopreparations Ltd. Bacteriophage Therapy Major Business
Table 26. Eliava Biopreparations Ltd. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 27. Eliava Biopreparations Ltd. SWOT Analysis
Table 28. Eliava Biopreparations Ltd. Bacteriophage Therapy Product and Solutions
Table 29. Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. InnoPhage, Ltd Corporate Information, Location and Competitors
Table 31. InnoPhage, Ltd Bacteriophage Therapy Major Business
Table 32. InnoPhage, Ltd Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 33. InnoPhage, Ltd SWOT Analysis
Table 34. InnoPhage, Ltd Bacteriophage Therapy Product and Solutions
Table 35. InnoPhage, Ltd Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Pherecydes Pharma Corporate Information, Location and Competitors
Table 37. Pherecydes Pharma Bacteriophage Therapy Major Business
Table 38. Pherecydes Pharma Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 39. Pherecydes Pharma SWOT Analysis
Table 40. Pherecydes Pharma Bacteriophage Therapy Product and Solutions
Table 41. Pherecydes Pharma Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Eligo Bioscience SA Corporate Information, Location and Competitors
Table 43. Eligo Bioscience SA Bacteriophage Therapy Major Business
Table 44. Eligo Bioscience SA Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 45. Eligo Bioscience SA SWOT Analysis
Table 46. Eligo Bioscience SA Bacteriophage Therapy Product and Solutions
Table 47. Eligo Bioscience SA Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Nextbiotics Corporate Information, Location and Competitors
Table 49. Nextbiotics Bacteriophage Therapy Major Business
Table 50. Nextbiotics Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 51. Nextbiotics SWOT Analysis
Table 52. Nextbiotics Bacteriophage Therapy Product and Solutions
Table 53. Nextbiotics Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Phagelux Inc. Corporate Information, Location and Competitors
Table 55. Phagelux Inc. Bacteriophage Therapy Major Business
Table 56. Phagelux Inc. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 57. Phagelux Inc. SWOT Analysis
Table 58. Phagelux Inc. Bacteriophage Therapy Product and Solutions
Table 59. Phagelux Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. TechnoPhage Corporate Information, Location and Competitors
Table 61. TechnoPhage Bacteriophage Therapy Major Business
Table 62. TechnoPhage Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 63. TechnoPhage SWOT Analysis
Table 64. TechnoPhage Bacteriophage Therapy Product and Solutions
Table 65. TechnoPhage Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Intodeworld, Inc. Corporate Information, Location and Competitors
Table 67. Intodeworld, Inc. Bacteriophage Therapy Major Business
Table 68. Intodeworld, Inc. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 69. Intodeworld, Inc. SWOT Analysis
Table 70. Intodeworld, Inc. Bacteriophage Therapy Product and Solutions
Table 71. Intodeworld, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Fixed-phage Ltd. Corporate Information, Location and Competitors
Table 73. Fixed-phage Ltd. Bacteriophage Therapy Major Business
Table 74. Fixed-phage Ltd. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 75. Fixed-phage Ltd. SWOT Analysis
Table 76. Fixed-phage Ltd. Bacteriophage Therapy Product and Solutions
Table 77. Fixed-phage Ltd. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Phagomed Biopharma GmbH. Corporate Information, Location and Competitors
Table 79. Phagomed Biopharma GmbH. Bacteriophage Therapy Major Business
Table 80. Phagomed Biopharma GmbH. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 81. Phagomed Biopharma GmbH. SWOT Analysis
Table 82. Phagomed Biopharma GmbH. Bacteriophage Therapy Product and Solutions
Table 83. Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. ContraFect Corporation Corporate Information, Location and Competitors
Table 85. ContraFect Corporation Bacteriophage Therapy Major Business
Table 86. ContraFect Corporation Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 87. ContraFect Corporation SWOT Analysis
Table 88. ContraFect Corporation Bacteriophage Therapy Product and Solutions
Table 89. ContraFect Corporation Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. BiomX Ltd. Corporate Information, Location and Competitors
Table 91. BiomX Ltd. Bacteriophage Therapy Major Business
Table 92. BiomX Ltd. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 93. BiomX Ltd. SWOT Analysis
Table 94. BiomX Ltd. Bacteriophage Therapy Product and Solutions
Table 95. BiomX Ltd. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. EnBiotix, Inc. Corporate Information, Location and Competitors
Table 97. EnBiotix, Inc. Bacteriophage Therapy Major Business
Table 98. EnBiotix, Inc. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 99. EnBiotix, Inc. SWOT Analysis
Table 100. EnBiotix, Inc. Bacteriophage Therapy Product and Solutions
Table 101. EnBiotix, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. PhagePro, Inc. Corporate Information, Location and Competitors
Table 103. PhagePro, Inc. Bacteriophage Therapy Major Business
Table 104. PhagePro, Inc. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 105. PhagePro, Inc. SWOT Analysis
Table 106. PhagePro, Inc. Bacteriophage Therapy Product and Solutions
Table 107. PhagePro, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Micreos BV Bacteriophage Therapy Route of Administration and Application
Table 109. Micreos BV Bacteriophage Therapy Major Business
Table 110. Micreos BV Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 111. Micreos BV SWOT Analysis
Table 112. Micreos BV Bacteriophage Therapy Product and Solutions
Table 113. Micreos BV Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Phi Therapeutics Corporate Information, Location and Competitors
Table 115. Phi Therapeutics Bacteriophage Therapy Major Business
Table 116. Phi Therapeutics Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 117. Phi Therapeutics SWOT Analysis
Table 118. Phi Therapeutics Bacteriophage Therapy Product and Solutions
Table 119. Phi Therapeutics Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. Adaptive Phage Therapeutics, Inc. Corporate Information, Location and Competitors
Table 121. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Major Business
Table 122. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 123. Adaptive Phage Therapeutics, Inc. SWOT Analysis
Table 124. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product and Solutions
Table 125. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 126. Global Bacteriophage Therapy Revenue (Million USD) by Players (2015-2020)
Table 127. Global Bacteriophage Therapy Revenue Share by Players (2015-2020)
Table 128. Global Bacteriophage Therapy Revenue (Million USD) by Regions (2015-2020)
Table 129. Global Bacteriophage Therapy Revenue Market Share by Regions (2015-2020)
Table 130. North America Bacteriophage Therapy Revenue by Countries (2015-2020)
Table 131. North America Bacteriophage Therapy Revenue Market Share by Countries (2015-2020)
Table 132. Europe Bacteriophage Therapy Revenue (Million USD) by Countries (2015-2020)
Table 133. Asia-Pacific Bacteriophage Therapy Revenue (Million USD) by Countries (2015-2020)
Table 134. South America Bacteriophage Therapy Revenue by Countries (2015-2020)
Table 135. South America Bacteriophage Therapy Revenue Market Share by Countries (2015-2020)
Table 136. Middle East and Africa Bacteriophage Therapy Revenue (Million USD) by Countries (2015-2020)
Table 137. Middle East and Africa Bacteriophage Therapy Revenue Market Share by Countries (2015-2020)
Table 138. Global Bacteriophage Therapy Revenue (Million USD) by Type (2015-2020)
Table 139. Global Bacteriophage Therapy Revenue Share by Type (2015-2020)
Table 140. Global Bacteriophage Therapy Revenue Forecast by Type (2021-2025)
Table 141. Global Bacteriophage Therapy Revenue by Application (2015-2020)
Table 142. Global Bacteriophage Therapy Revenue Share by Application (2015-2020)
Table 143. Global Bacteriophage Therapy Revenue Forecast by Application (2021-2025)
Table 144. Global Bacteriophage Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Bacteriophage Therapy Picture
Figure 2. Global Bacteriophage Therapy Revenue Market Share by Route of Administration in 2019
Figure 3. Oral Picture
Figure 4. Topical Picture
Figure 5. Parenteral Picture
Figure 6. Bacteriophage Therapy Revenue Market Share by Application in 2019
Figure 7. Organ Transplantation Picture
Figure 8. Bacterial Infections Picture
Figure 9. Alcoholic Hepatitis Picture
Figure 10. Other Picture
Figure 11. Global Bacteriophage Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Bacteriophage Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Bacteriophage Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Bacteriophage Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Bacteriophage Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Bacteriophage Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Bacteriophage Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Bacteriophage Therapy Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Bacteriophage Therapy Revenue Market Share in 2019
Figure 20. Global Top 10 Players Bacteriophage Therapy Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Bacteriophage Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Bacteriophage Therapy Revenue Market Share by Regions (2015-2020)
Figure 24. Global Bacteriophage Therapy Revenue Market Share by Regions in 2018
Figure 25. North America Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 26. Europe Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 28. South America Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 30. North America Bacteriophage Therapy Revenue Market Share by Countries (2015-2020)
Figure 31. North America Bacteriophage Therapy Revenue Market Share by Countries in 2019
Figure 32. USA Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 33. Canada Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 35. Europe Bacteriophage Therapy Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Bacteriophage Therapy Revenue Market Share by Countries in 2019
Figure 37. Germany Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 38. UK Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 39. France Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 40. Russia Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 41. Italy Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Bacteriophage Therapy Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Bacteriophage Therapy Revenue Market Share by Countries in 2019
Figure 44. China Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 45. Japan Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 46. Korea Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 47. India Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 49. South America Bacteriophage Therapy Revenue Market Share by Countries (2015-2020)
Figure 50. South America Bacteriophage Therapy Revenue Market Share by Countries in 2019
Figure 51. Brazil Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Bacteriophage Therapy Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Bacteriophage Therapy Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 56. UAE Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Bacteriophage Therapy Revenue and Growth Rate (2015-2020)
Figure 59. Global Bacteriophage Therapy Revenue Share by Type (2015-2020)
Figure 60. Global Bacteriophage Therapy Revenue Share by Type in 2019
Figure 61. Global Bacteriophage Therapy Market Share Forecast by Type (2021-2025)
Figure 62. Global Oral Revenue Growth Rate (2015-2020)
Figure 63. Global Topical Revenue Growth Rate (2015-2020)
Figure 64. Global Parenteral Revenue Growth Rate (2015-2020)
Figure 65. Global Bacteriophage Therapy Revenue Share by Application (2015-2020)
Figure 66. Global Bacteriophage Therapy Revenue Share by Application in 2019
Figure 67. Global Bacteriophage Therapy Market Share Forecast by Application (2021-2025)
Figure 68. Global Organ Transplantation Revenue Growth Rate (2015-2020)
Figure 69. Global Bacterial Infections Revenue Growth Rate (2015-2020)
Figure 70. Global Alcoholic Hepatitis Revenue Growth Rate (2015-2020)
Figure 71. Global Other Revenue Growth Rate (2015-2020)
Figure 72. Global Bacteriophage Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Bacteriophage Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Bacteriophage Therapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Bacteriophage Therapy Revenue Market Forecast (2021-2025)
Figure 76. Europe Bacteriophage Therapy Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Bacteriophage Therapy Revenue Market Forecast (2021-2025)
Figure 78. South America Bacteriophage Therapy Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Bacteriophage Therapy Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
エストロゲン補充療法の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Estrogen Replacement Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…- パラフィン理学療法の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Paraffin Physical Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Paraffin Physical T…
- 放射線療法用イモビライザーの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Radiation Therapy Immobilizers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Radiation Ther…
- 放射線療法用QAシステムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Radiation Therapy QA Systems market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Radiation Therap…
- ミリ波治療器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Millimeter Wave Therapy Instrument market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Millimeter…